The Ischemic Optic Neuropathy Treatment Market To Witness A Paradigm Shift With Technological Advancements - PowerPoint PPT Presentation

About This Presentation
Title:

The Ischemic Optic Neuropathy Treatment Market To Witness A Paradigm Shift With Technological Advancements

Description:

According to a new report published by Persistence Market Research, the global ischemic optic neuropathy treatment market valued at US$ 187.7 Mn in 2020, and is predicted to expand at a CAGR of close to 4% over the forecast period (2021-2031). – PowerPoint PPT presentation

Number of Views:11

less

Transcript and Presenter's Notes

Title: The Ischemic Optic Neuropathy Treatment Market To Witness A Paradigm Shift With Technological Advancements


1
Ischemic Optic Neuropathy Treatment Market
Report Id PMRREP23077 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas


Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
The Ischemic Optic Neuropathy Treatment Market To
Witness A Paradigm Shift With Technological
Advancements
  • Ischemic optic neuropathy occurs because of a
    small vessel infraction of the optic nerve, and
    is a significant reason for impaired vision or
    blindness. Increasing utilization of newly
    approved intravitreal implants for the treatment
    of optic nerve disorders is expected to drive the
    market over the coming years.
  • With developing awareness toward eye-associated
    inconveniences that give rise to impaired vision,
    diabetic patients and the geriatric population in
    developed nations are believed to have a
    proactive methodology for treatment-associated
    difficulties instead of reactive treatment, which
    likewise supports the development of the market.
  • Drug manufacturing and leading pharmaceutical
    companies from emerging nations are significantly
    investing in research development activities,
    new technologies, and infrastructure in
    ophthalmology therapeutics to capture a market
    share in the developing burden of eye infections.
  • According to a new report published by
    Persistence Market Research, the global ischemic
    optic neuropathy treatment market valued at US
    187.7 Mn in 2020, and is predicted to expand at
    a CAGR of close to 4 over the forecast period
    (2021-2031).

Get Sample Copy of this Report _at_ https//www.persi
stencemarketresearch.com/samples/23077
4
What Does the Report Cover?
Persistence Market Research offers a unique
perspective and actionable insights on the
ischemic optic neuropathy treatment market in its
latest study, presenting a historical demand
assessment of 2016  2020 and projections for
2021  2031. The research study is based on drug
class (corticosteroids, antimetabolites,
anticoagulants, serotonin and norepinephrine
reuptake inhibitors (SNRIs), and nonsteroidal
anti-inflammatory drugs (NSAIDs)), route of
administration (oral and injectable), disease
(anterior ischemic optic neuropathy and posterior
ischemic optic neuropathy), and distribution
channel (hospital pharmacies, retail pharmacies,
drug stores, and online pharmacies), across seven
key regions of the world.
Access Full Report _at_ https//www.persistencemarket
research.com/checkout/23077
5
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com